L-Lysine α-Oxidase: Enzyme with Anticancer Properties
L-lysine α-oxidase (LO), one of L-amino acid oxidases, deaminates L-lysine with the yield of H<sub>2</sub>O<sub>2</sub>, ammonia, and α-keto-ε-aminocaproate. Multiple in vitro and in vivo studies have reported cytotoxic, antitumor, antimetastatic, and antitumor activity of LO...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | L-lysine α-oxidase (LO), one of L-amino acid oxidases, deaminates L-lysine with the yield of H<sub>2</sub>O<sub>2</sub>, ammonia, and α-keto-ε-aminocaproate. Multiple in vitro and in vivo studies have reported cytotoxic, antitumor, antimetastatic, and antitumor activity of LO. Unlike asparaginase, LO has a dual mechanism of action: depletion of L-lysine and formation of H<sub>2</sub>O<sub>2</sub>, both targeting tumor growth. Prominent results were obtained on murine and human tumor models, including human colon cancer xenografts HCT 116, LS174T, and T47D with maximum T/C 12, 37, and 36%, respectively. The data obtained from human cancer xenografts in immunodeficient mice confirm the potential of LO as an agent for colon cancer treatment. In this review, we discuss recently discovered molecular mechanisms of biological action and the potential of LO as anticancer enzyme. |
|---|---|
| Item Description: | 10.3390/ph14111070 1424-8247 |